TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 5 | 4 | 21 | 20 | 63 | -3 | 18 |
| S | %wins | 0 | 50 | 0 | 0 | 0 | 100 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/08 17:15 | 3/10/08 | NABI | Nabi Biopharmaceuticals | DE | Health | BioPrd | Biological Products, (No Diag | Siegel Jordan I | MD | O | SVP Fin. | S | -220 | 3.26 | 1 | -68 | -79 | 18 | D | -16 | -26 | 4 | -3 | 1 | 0 | -7 | 1 | 8 | 11 | 26 | 22 | 61 | -2 |
3/6/08 17:41 | 3/5/08 | NABI | Nabi Biopharmaceuticals | DE | Health | BioPrd | Biological Products, (No Diag | Siegel Jordan I | MD | O | SVP Fin. | S | -28 | 3.80 | 1 | -8 | -8 | 86 | D | -8 | -20 | 9 | 21 | 2 | 3 | 3 | -2 | 2 | -4 | 16 | 17 | 65 | -3 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |